Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 422

1.

CSF cutoffs for MCI due to AD depend on APOEε4 carrier status.

Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB.

Neurobiol Aging. 2019 Dec 30. pii: S0197-4580(19)30448-8. doi: 10.1016/j.neurobiolaging.2019.12.019. [Epub ahead of print]

PMID:
32029236
2.

A kinetics-based approach to amyloid PET semi-quantification.

Chincarini A, Peira E, Corosu M, Morbelli S, Bauckneht M, Capitanio S, Pardini M, Arnaldi D, Vellani C, D'Ambrosio D, Garibotto V, Assal F, Paghera B, Savelli G, Stefanelli A, Guerra UP, Nobili F.

Eur J Nucl Med Mol Imaging. 2020 Jan 25. doi: 10.1007/s00259-020-04689-y. [Epub ahead of print]

PMID:
31982991
3.

Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia.

Orso B, Mattei C, Arnaldi D, Massa F, Serafini G, Plantone D, Doglione E, Grafman J, Nobili F, Pardini M.

Am J Geriatr Psychiatry. 2019 Dec 17. pii: S1064-7481(19)30586-X. doi: 10.1016/j.jagp.2019.12.007. [Epub ahead of print]

PMID:
31928846
4.

Metabolic network abnormalities in drug-naïve Parkinson's Disease.

Schindlbeck KA, Lucas-Jiménez O, Tang CC, Morbelli S, Arnaldi D, Pardini M, Pagani M, Ibarretxe-Bilbao N, Ojeda N, Nobili F, Eidelberg D.

Mov Disord. 2019 Dec 24. doi: 10.1002/mds.27960. [Epub ahead of print]

PMID:
31872507
5.

Metabolic correlates of dopaminergic loss in dementia with lewy bodies.

Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Vöglein J, Schnabel J, Unterrainer M, Perneczky R, Pogarell O, Buerger K, Catak C, Bartenstein P, Cumming P, Ewers M, Danek A, Levin J, Aarsland D, Nobili F, Rominger A, Brendel M.

Mov Disord. 2019 Dec 16. doi: 10.1002/mds.27945. [Epub ahead of print]

6.

Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.

Meles SK, Renken RJ, Pagani M, Teune LK, Arnaldi D, Morbelli S, Nobili F, van Laar T, Obeso JA, Rodríguez-Oroz MC, Leenders KL.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):437-450. doi: 10.1007/s00259-019-04570-7. Epub 2019 Nov 25.

7.

What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons.

Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, Dubois B, Escudero J, Fernández A, Frisoni G, Guntekin B, Hajos M, Hampel H, Ifeachor E, Kilborn K, Kumar S, Johnsen K, Johannsson M, Jeong J, LeBeau F, Lizio R, Lopes da Silva F, Maestú F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Olichney J, Onofrj M, Palop JJ, Rowan M, Stocchi F, Struzik ZM, Tanila H, Teipel S, Taylor JP, Weiergräber M, Yener G, Young-Pearse T, Drinkenburg WH, Randall F.

Neurobiol Aging. 2020 Jan;85:58-73. doi: 10.1016/j.neurobiolaging.2019.09.008. Epub 2019 Sep 19. Review.

PMID:
31739167
8.

Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients.

Boccardi M, Nicolosi V, Festari C, Bianchetti A, Cappa S, Chiasserini D, Falini A, Guerra UP, Nobili F, Padovani A, Sancesario G, Morbelli S, Parnetti L, Tiraboschi P, Muscio C, Perani D, Pizzini FB, Beltramello A, Salvini Porro G, Ciaccio M, Schillaci O, Trabucchi M, Tagliavini F, Frisoni GB.

Eur J Neurol. 2020 Mar;27(3):475-483. doi: 10.1111/ene.14117. Epub 2019 Dec 18.

PMID:
31692118
9.

Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.

Massa F, Farotti L, Eusebi P, Capello E, Dottorini ME, Tranfaglia C, Bauckneht M, Morbelli S, Nobili F, Parnetti L.

J Alzheimers Dis. 2019;72(4):1193-1207. doi: 10.3233/JAD-190539.

PMID:
31683477
10.

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.

Bauckneht M, Capitanio S, Raffa S, Roccatagliata L, Pardini M, Lapucci C, Marini C, Sambuceti G, Inglese M, Gallo P, Cecchin D, Nobili F, Morbelli S.

EJNMMI Radiopharm Chem. 2019 Apr 8;4(1):6. doi: 10.1186/s41181-019-0058-3. Review.

11.

Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution.

Massa F, Meli R, Morbelli S, Nobili F, Pardini M.

Ann Transl Med. 2019 Jul;7(Suppl 3):S133. doi: 10.21037/atm.2019.05.81. No abstract available.

12.

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.

van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Frolich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Frisoni GB, Spiru L, Freund-Levi Y, Wallin AK, Hampel H, Soininen H, Tsolaki M, Verhey F, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka SK, Santana I, Baldeiras I, de Mendonça A, Silva D, Chetelat G, Egret S, Palmqvist S, Hansson O, Visser PJ, Berkhof J, van der Flier WM; Alzheimer's Disease Neuroimaging Initiative.

Lancet Neurol. 2019 Nov;18(11):1034-1044. doi: 10.1016/S1474-4422(19)30283-2. Epub 2019 Sep 13.

PMID:
31526625
13.

School level of children carrying a HNF1B variant or a deletion.

Laliève F, Decramer S, Heidet L, Baudouin V, Lahoche A, Llanas B, Cochat P, Tenenbaum J, Lavocat MP, Eckart P, Broux F, Roussey G, Cloarec S, Vrillon I, Dunand O, Bessenay L, Tsimaratos M, Nobili F, Pietrement C, De Parscau L, Bonneville V, Rodier N, Saint-Martin C, Chassaing N, Michel-Calemard L, Moriniere V, Bellanné-Chantelot C, Bahans C, Guigonis V.

Eur J Hum Genet. 2020 Jan;28(1):56-63. doi: 10.1038/s41431-019-0490-6. Epub 2019 Sep 3.

PMID:
31481685
14.

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey.

Bertens D, Vos S, Kehoe P, Wolf H, Nobili F, Mendonça A, van Rossum I, Hort J, Molinuevo JL, Heneka M, Petersen R, Scheltens P, Visser PJ.

Alzheimers Res Ther. 2019 Aug 22;11(1):74. doi: 10.1186/s13195-019-0525-9.

15.

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease.

Ramusino MC, Garibotto V, Bacchin R, Altomare D, Dodich A, Assal F, Mendes A, Costa A, Tinazzi M, Morbelli SD, Bauckneht M, Picco A, Dottorini ME, Tranfaglia C, Farotti L, Salvadori N, Moretti D, Savelli G, Tarallo A, Nobili F, Parapini M, Cavaliere C, Salvatore E, Salvatore M, Boccardi M, Frisoni GB.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):270-280. doi: 10.1007/s00259-019-04466-6. Epub 2019 Aug 6.

PMID:
31388720
16.

Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes.

Belvederi Murri M, Respino M, Proietti L, Bugliani M, Pereira B, D'Amico E, Sangregorio F, Villa V, Trinchero V, Brugnolo A, Girtler N, Nobili F, Amore M.

J Affect Disord. 2019 Oct 1;257:166-172. doi: 10.1016/j.jad.2019.07.052. Epub 2019 Jul 5.

PMID:
31301619
17.

Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis?

Lapucci C, Boffa G, Massa F, Franciotta D, Castelletti L, Uccelli A, Morbelli S, Nobili F, Benedetti L, Roccatagliata L.

Eur J Neurol. 2019 Oct;26(10):e86-e87. doi: 10.1111/ene.13977. Epub 2019 May 17. No abstract available.

PMID:
31099961
18.

Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Pilotto A, Schiano di Cola F, Premi E, Grasso R, Turrone R, Gipponi S, Scalvini A, Cottini E, Paghera B, Garibotto V, Rizzetti MC, Bonanni L, Borroni B, Morbelli S, Nobili F, Guerra UP, Perani D, Padovani A.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1642-1651. doi: 10.1007/s00259-019-04324-5. Epub 2019 May 16.

PMID:
31098748
19.

Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis.

Boffa G, Lapucci C, Morbelli SD, Nobili FM.

Q J Nucl Med Mol Imaging. 2019 Jun;63(2):225-226. doi: 10.23736/S1824-4785.19.03171-6. Epub 2019 May 8.

PMID:
31089076
20.

Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC).

Chincarini A, Peira E, Morbelli S, Pardini M, Bauckneht M, Arbizu J, Castelo-Branco M, Büsing KA, de Mendonça A, Didic M, Dottorini M, Engelborghs S, Ferrarese C, Frisoni GB, Garibotto V, Guedj E, Hausner L, Hugon J, Verhaeghe J, Mecocci P, Musarra M, Queneau M, Riverol M, Santana I, Guerra UP, Nobili F.

Neuroimage Clin. 2019;23:101846. doi: 10.1016/j.nicl.2019.101846. Epub 2019 May 4.

21.

Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data.

Manzanera OM, Meles SK, Leenders KL, Renken RJ, Pagani M, Arnaldi D, Nobili F, Obeso J, Oroz MR, Morbelli S, Maurits NM.

Int J Neural Syst. 2019 Nov;29(9):1950010. doi: 10.1142/S0129065719500102. Epub 2019 Mar 3.

PMID:
31046514
22.

Corrigendum to "Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases" [Clin. Neurophysiol. 129 (2018) 766-782].

Babiloni C, Percio CD, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Orzi F, Buttinelli C, Giubilei F, Bonanni L, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Garn H, Fraioli L, Pievani M, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Başar E, Yener G, Emek-Savaş DD, Triggiani AI, Taylor JP, De Pandis MF, Vacca L, Frisoni GB, Stocchi F.

Clin Neurophysiol. 2019 Jun;130(6):1078. doi: 10.1016/j.clinph.2019.02.006. Epub 2019 Apr 9. No abstract available.

PMID:
30979693
23.

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.

Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):49-58. doi: 10.3233/JAD-181016.

PMID:
30958351
24.

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.

Calvo A, Chiò A, Pagani M, Cammarosano S, Dematteis F, Moglia C, Solero L, Manera U, Martone T, Brunetti M, Balma M, Castellano G, Barberis M, Cistaro A, Artusi CA, Vasta R, Montanaro E, Romagnolo A, Iazzolino B, Canosa A, Carrara G, Valentini C, Li TQ, Nobili F, Lopiano L, Rizzone MG.

J Neurol. 2019 Jul;266(7):1633-1642. doi: 10.1007/s00415-019-09305-0. Epub 2019 Apr 4.

PMID:
30949819
25.

Tin-Decorated Reduced Graphene Oxide and NaLi0.2Ni0.25Mn0.75O as Electrode Materials for Sodium-Ion Batteries.

Prosini PP, Carewska M, Cento C, Tarquini G, Maroni F, Birrozzi A, Nobili F.

Materials (Basel). 2019 Apr 1;12(7). pii: E1074. doi: 10.3390/ma12071074.

26.

Metabolic patterns across core features in dementia with lewy bodies.

Morbelli S, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F.

Ann Neurol. 2019 May;85(5):715-725. doi: 10.1002/ana.25453. Epub 2019 Mar 22.

PMID:
30805951
27.

Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases.

Babiloni C, Del Percio C, Pascarelli MT, Lizio R, Noce G, Lopez S, Rizzo M, Ferri R, Soricelli A, Nobili F, Arnaldi D, Famà F, Orzi F, Buttinelli C, Giubilei F, Salvetti M, Cipollini V, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Aarsland D, Parnetti L, Farotti L, Marizzoni M, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Yener G, Emek-Savaş DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Hampel H, Frisoni GB, De Pandis MF, Bonanni L.

Neurobiol Aging. 2019 May;77:112-127. doi: 10.1016/j.neurobiolaging.2019.01.013. Epub 2019 Jan 24.

PMID:
30797169
28.

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.

Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A.

Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.

29.

Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.

Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BNM, Ossenkoppele R, Didic M, Guedj E, Arnaldi D, Massa F, Grazzini M, Pardini M, Mecocci P, Dottorini ME, Bauckneht M, Sambuceti G, Nobili F.

J Alzheimers Dis. 2019;68(1):383-394. doi: 10.3233/JAD-181022.

PMID:
30776000
30.

Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.

Carbone F, Dallegri F, Montecucco F, Poggi A, Nobili FM, Cacciapaglia F, Afeltra A, Moccetti T, Colombo BM.

Eur J Clin Invest. 2019 May;49(5):e13089. doi: 10.1111/eci.13089. Epub 2019 Mar 3.

PMID:
30767212
31.

Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.

Arnaldi D, Meles SK, Giuliani A, Morbelli S, Renken RJ, Janzen A, Mayer G, Jonsson C, Oertel WH, Nobili F, Leenders KL, Pagani M; REMPET Study Group.

J Parkinsons Dis. 2019;9(1):229-239. doi: 10.3233/JPD-181468.

PMID:
30741687
32.

Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis.

Marini C, Morbelli S, Cistaro A, Campi C, Caponnetto C, Bauckneht M, Bellini A, Buschiazzo A, Calamia I, Beltrametti MC, Margotti S, Fania P, Poggi I, Cabona C, Capitanio S, Piva R, Calvo A, Moglia C, Canosa A, Massone A, Nobili F, Mancardi G, Chiò A, Piana M, Sambuceti G.

Brain. 2018 Aug 1;141(8):2272-2279. doi: 10.1093/brain/awy152.

33.

FDG-PET patterns associated with underlying pathology in corticobasal syndrome.

Pardini M, Huey ED, Spina S, Kreisl WC, Morbelli S, Wassermann EM, Nobili F, Ghetti B, Grafman J.

Neurology. 2019 Mar 5;92(10):e1121-e1135. doi: 10.1212/WNL.0000000000007038. Epub 2019 Jan 30.

PMID:
30700592
34.

Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.

Frémeaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, Novo R, Llanas B, Nobili F, Roussey G, Cailliez M, Ulinski T, Deschênes G, Alberti C, Weill FX, Mariani P, Loirat C.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):364-377. doi: 10.2215/CJN.05830518. Epub 2019 Jan 23.

PMID:
30674459
35.

Pelvic floor muscle training for prevention and treatment of urinary incontinence during pregnancy and after childbirth and its effect on urinary system and supportive structures assessed by objective measurement techniques.

Soave I, Scarani S, Mallozzi M, Nobili F, Marci R, Caserta D.

Arch Gynecol Obstet. 2019 Mar;299(3):609-623. doi: 10.1007/s00404-018-5036-6. Epub 2019 Jan 16. Review.

PMID:
30649605
36.

Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.

Massa F, Arnaldi D, De Cesari F, Girtler N, Brugnolo A, Grazzini M, Bauckneht M, Meli R, Morbelli S, Pardini M, Sambuceti G, De Carli F, Tiraboschi P, Nobili F.

Neurobiol Aging. 2019 Apr;76:9-17. doi: 10.1016/j.neurobiolaging.2018.12.001. Epub 2018 Dec 13.

PMID:
30611093
37.

A new frontier for amyloid PET imaging: multiple sclerosis.

Morbelli S, Bauckneht M, Capitanio S, Pardini M, Roccatagliata L, Nobili F.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):276-279. doi: 10.1007/s00259-018-4232-8. Epub 2018 Dec 15. No abstract available.

PMID:
30554257
38.

A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium.

Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snædal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Mar;15(3):400-409. doi: 10.1016/j.jalz.2018.09.011. Epub 2018 Nov 12.

PMID:
30439333
39.

Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease.

Novi G, Canosa A, Nobili F, Bongianni M, Zanusso G, Balestrino M, Roccatagliata L.

Eur J Neurol. 2018 Dec;25(12):e127-e128. doi: 10.1111/ene.13807. No abstract available.

PMID:
30403324
40.

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoniand GB; and the PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):15-35. doi: 10.3233/JAD-180158.

PMID:
30400088
41.

Prenatal hypocalvaria after prolonged intrauterine exposure to angiotensin II receptor antagonists.

Lallemant M, Prévost S, Nobili F, Riethmuller D, Ramanah R, Seronde MF, Mottet N.

J Renin Angiotensin Aldosterone Syst. 2018 Oct-Dec;19(4):1470320318810940. doi: 10.1177/1470320318810940.

42.

Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.

De Carli F, Nobili F, Pagani M, Bauckneht M, Massa F, Grazzini M, Jonsson C, Peira E, Morbelli S, Arnaldi D; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):334-347. doi: 10.1007/s00259-018-4197-7. Epub 2018 Oct 31.

PMID:
30382303
43.

Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms.

Babiloni C, Del Percio C, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Orzi F, Buttinelli C, Giubilei F, Bonanni L, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Fraioli L, Parnetti L, Farotti L, Pievani M, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Yener G, Emek-Savaş DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Frisoni GB, De Pandis MF.

Neurobiol Aging. 2019 Jan;73:9-20. doi: 10.1016/j.neurobiolaging.2018.08.010. Epub 2018 Aug 30.

PMID:
30312790
44.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

45.

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.

Albani D, Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):37-48. doi: 10.3233/JAD-180321.

PMID:
30149449
46.

Cortical Network Topology in Prodromal and Mild Dementia Due to Alzheimer's Disease: Graph Theory Applied to Resting State EEG.

Franciotti R, Falasca NW, Arnaldi D, Famà F, Babiloni C, Onofrj M, Nobili FM, Bonanni L.

Brain Topogr. 2019 Jan;32(1):127-141. doi: 10.1007/s10548-018-0674-3. Epub 2018 Aug 25.

47.

Neonatal renal replacement therapy: An ethical reflection for a crucial decision.

Linder E, Burguet A, Nobili F, Vieux R.

Arch Pediatr. 2018 Aug;25(6):371-377. doi: 10.1016/j.arcped.2018.06.002. Epub 2018 Aug 22.

PMID:
30143372
48.

Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study.

Lizio R, Babiloni C, Del Percio C, Losurdo A, Vernò L, De Tommaso M, Montemurno A, Dalfino G, Cirillo P, Soricelli A, Ferri R, Noce G, Pascarelli MT, Catania V, Nobili F, Famá F, Orzi F, Giubilei F, Buttinelli C, Triggiani AI, Frisoni GB, Scisci AM, Mastrofilippo N, Procaccini DA, Gesualdo L.

J Alzheimers Dis. 2018;65(3):897-915. doi: 10.3233/JAD-180245.

PMID:
30103322
49.

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus.

Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Neurol. 2018 Oct;25(10):1201-1217. doi: 10.1111/ene.13728. Epub 2018 Jul 20.

PMID:
29932266
50.

Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.

Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Salvatore M, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):3-14. doi: 10.3233/JAD-180152.

PMID:
29914031

Supplemental Content

Loading ...
Support Center